← All patents

US12070444B2

Modulation of molecular markers using S-equol

University of Texas System

Abstract

The present invention provides methods and compositions for modulating molecular markers, and hence treating or preventing breast cancer (e.g., triple-negative breast cancer) and melanoma with a pharmaceutically effective amount of S-equol or a pharmaceutical composition comprising S-equol. The S- …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Rong Li
Priority date
November 24, 2020
Filing date
November 24, 2021
Grant date
August 27, 2024
Publication date
August 27, 2024
Language
en
Metadata fetched
August 29, 2026 00:32